Tu banner alternativo

Otilonium bromide

This article will address Otilonium bromide, a current topic that has aroused the interest of different sectors of society. Otilonium bromide has gained relevance in recent times and has generated a debate around its implications and repercussions. Through an exhaustive analysis, we will seek to offer a complete and objective view of Otilonium bromide, in order to provide readers with a deeper understanding of this topic. In addition, different perspectives and approaches will be examined that will allow Otilonium bromide to be approached from different angles, thus enriching the knowledge and debate around this topic.

Tu banner alternativo

Otilonium bromide
Clinical data
Trade namesSpasmoctyl 40, Doralin, Menoctyl
AHFS/Drugs.comInternational Drug Names
ATC code
Pharmacokinetic data
Bioavailability1.1%[1][unreliable source?]
Identifiers
  • N,N-Diethyl-N-methyl-2-(4-benzoyloxy)ethanaminium bromide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.043.128 Edit this at Wikidata
Chemical and physical data
FormulaC29H43BrN2O4
Molar mass563.577 g·mol−1
3D model (JSmol)
  • CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC(C)(CC)CC.
  • InChI=1S/C29H42N2O4.BrH/c1-5-8-9-10-11-14-22-34-27-16-13-12-15-26(27)28(32)30-25-19-17-24(18-20-25)29(33)35-23-21-31(4,6-2)7-3;/h12-13,15-20H,5-11,14,21-23H2,1-4H3;1H ☒N
  • Key:VWZPIJGXYWHBOW-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Otilonium bromide is a drug used to treat abdominal pain caused by irritable bowel syndrome. It is an antispasmodic, which is useful to treat the symptoms of irritable bowel syndrome by reducing abdominal spasms (colic), bloating, pain, and gut motility.

It is an antimuscarinic and calcium channel blocker used to relieve spasmodic pain of the gut, especially in irritable bowel syndrome.[2] This means it works in the gut themselves, by relaxing the small muscles of the intestines, which results in relieving cramps and therefore reduces pain.

Medical uses

A pooled analysis of three clinical trials suggest that otilonium bromide is more effective than placebo for the treatment of irritable bowel syndrome.[3]

Pharmacology

Otilonium bromide binds to both muscarinic receptors and tachykinin NK2 receptors.[4] It has been shown to inhibit L-type and T-type calcium channels, actions which may contribute to or determine its effects in the gut.[5][6]

When taken orally, very little of the drug is absorbed into the rest of the body,[7] which means that most of its actions remain confined to the gastrointestinal system.

Adverse effects

Otilonium bromide is generally well tolerated and does not have the side-effects observed with similar classes of drugs.[8] A case of cardiovascular toxicity was reported due to an overdose.[9][10]

References

  1. ^ Shin BS, Kim JJ, Kim J, Hu SK, Kim HJ, Hong SH, et al. (January 2008). "Oral bioavailability and enterohepatic recirculation of otilonium bromide in rats". Archives of Pharmacal Research. 31 (1): 117–124. doi:10.1007/s12272-008-1129-2. PMID 18277617.
  2. ^ "Dismox" (PDF). Archived from the original (PDF) on 4 March 2016.
  3. ^ Clavé P, Tack J (March 2017). "Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis". Therapeutic Advances in Gastroenterology. 10 (3): 311–322. doi:10.1177/1756283X16681708. PMC 5305018. PMID 28246548.
  4. ^ Evangelista S (1999). "Otilonium bromide: a selective spasmolytic for the gastrointestinal tract". The Journal of International Medical Research. 27 (5): 207–222. doi:10.1177/030006059902700501. PMID 10689627.
  5. ^ Martin MT, Hove-Madsen L, Jimenez M (April 2004). "Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon". Neurogastroenterology and Motility. 16 (2): 175–183. doi:10.1111/j.1365-2982.2004.00518.x. PMID 15086871. S2CID 7315438.
  6. ^ Strege PR, Sha L, Beyder A, Bernard CE, Perez-Reyes E, Evangelista S, et al. (May 2010). "T-type Ca(2+) channel modulation by otilonium bromide". American Journal of Physiology. Gastrointestinal and Liver Physiology. 298 (5): G706 – G713. doi:10.1152/ajpgi.00437.2009. PMC 2867415. PMID 20203058.
  7. ^ Shin BS, Kim JJ, Kim J, Hu SK, Kim HJ, Hong SH, et al. (January 2008). "Oral bioavailability and enterohepatic recirculation of otilonium bromide in rats". Archives of Pharmacal Research. 31 (1): 117–124. doi:10.1007/s12272-008-1129-2. PMID 18277617. S2CID 25727036.
  8. ^ Evangelista S (November 2004). "Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome". Current Pharmaceutical Design. 10 (28): 3561–3568. doi:10.2174/1381612043382972. PMID 15579053.
  9. ^ Zaki SA, Helal ME, Rashid A (March 2022). "Cardiovascular Toxicity Due to Otilonium Bromide Overdose: A Case Report". The Journal of Emergency Medicine. 62 (3): e47 – e50. doi:10.1016/j.jemermed.2021.10.025. PMID 35031171.
  10. ^ "Submission for the classification of Otilonium bromide 40 mg film-coated tables (10 and 30 tablet pack) as Pharmacist Only" (PDF). Arai BioFarma Limited.
Wikious
Boobota
Sagapedia